Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 10
311
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

New bioactive flavonoid glycosides with antioxidant activity from the stem bark of Olax subscorpioidea Oliv

, , , , , , & show all
Pages 1641-1650 | Received 20 Mar 2022, Accepted 22 Jul 2022, Published online: 03 Aug 2022
 

Abstract

A previously unreported gallocatechin glycoside, (2 R,3S) 4′-O-methyl-gallocatechin-3-O-α-ʟ-rhamnopyranoside (1) and an unseparable mixture of two previously undescribed dihydromyricetin glycosides, (2 R,3R) 4′-O-methyl-dihydromyricetin-3-O-α-ʟ-rhamnopyranoside (2a) and (2 R,3S) 4′-O-methyl-dihydromyricetin-3-O-α-ʟ-rhamnopyranoside (2 b) along with three known compounds were isolated from the n-butanol soluble fraction of the stem bark of Olax subscorpioidea Oliv. Their structures were elucidated by detailed spectroscopic analyses, including 1H NMR, 13C NMR, 1H-1H COSY, HSQC, HMBC, NOESY, HR-ESI-MS and chemical methods. The crude ethanol extract, the fractions, and some of the isolated compounds were screened for their antioxidant and antibacterial activities. They showed significant antioxidant activities with EC50 ranging from 6.29 to 18.19 µg/mL in 2,2-diphenyl-1-picrylhydrazyl (DPPH) method and EC50 ranging from 85.77 to 86.39 mmol FeSO4/g in ferric reducing antioxidant power (FRAP) methods compared with 2.29 µg/mL and 3.52 mmol FeSO4/g for the positive control (ʟ-ascorbic acid). Nevertheless, no inhibition was observed against the tested bacterial strains at a MIC less than 256 μg/mL.

Graphical Abstract

Conflict of interest

The authors declare no conflict of interest.

Additional information

Funding

We are grateful to the Alexander Von Humbolt Foundation (AvH), Bonn, Germany for the financial support of the present work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.